These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

151 related articles for article (PubMed ID: 23434896)

  • 1. Antimicrobial stewardship in the management of community-acquired pneumonia.
    Hurst JM; Bosso JA
    Curr Opin Infect Dis; 2013 Apr; 26(2):184-8. PubMed ID: 23434896
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Application of antimicrobial stewardship to optimise management of community acquired pneumonia.
    Bosso JA; Drew RH
    Int J Clin Pract; 2011 Jul; 65(7):775-83. PubMed ID: 21676120
    [TBL] [Abstract][Full Text] [Related]  

  • 3. What is the role of antimicrobial stewardship in improving outcomes of patients with CAP?
    Nussenblatt V; Avdic E; Cosgrove S
    Infect Dis Clin North Am; 2013 Mar; 27(1):211-28. PubMed ID: 23398876
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Community acquired bacterial pneumonia.
    Anevlavis S; Bouros D
    Expert Opin Pharmacother; 2010 Feb; 11(3):361-74. PubMed ID: 20085502
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Antibiotic stewardship in community-acquired pneumonia.
    Viasus D; Vecino-Moreno M; De La Hoz JM; Carratalà J
    Expert Rev Anti Infect Ther; 2017 Apr; 15(4):351-359. PubMed ID: 28002979
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Current treatment of community-acquired pneumonia.
    Liapikou A; Torres A
    Expert Opin Pharmacother; 2013 Jul; 14(10):1319-32. PubMed ID: 23663104
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Guidelines for the management of community-acquired pneumonia.
    Chaisson RE
    Am J Manag Care; 2000 Dec; 6(23 Suppl):S1211-5. PubMed ID: 11187445
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Antimicrobial stewardship: bridging the gap between quality care and cost.
    Goff DA
    Curr Opin Infect Dis; 2011 Feb; 24 Suppl 1():S11-20. PubMed ID: 21200180
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The role of new therapies for severe community-acquired pneumonia.
    Restrepo MI; Anzueto A
    Curr Opin Infect Dis; 2006 Dec; 19(6):557-64. PubMed ID: 17075331
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Emergency management of community-acquired bacterial pneumonia: what is new since the 2007 Infectious Diseases Society of America/American Thoracic Society guidelines.
    Moran GJ; Rothman RE; Volturo GA
    Am J Emerg Med; 2013 Mar; 31(3):602-12. PubMed ID: 23380120
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Community-acquired pneumonia: new management strategies for evolving pathogens and antimicrobial susceptibilities.
    Klugman KP; Low DE; Metlay J; Pechere JC; Weiss K
    Int J Antimicrob Agents; 2004 Nov; 24(5):411-22. PubMed ID: 15519470
    [TBL] [Abstract][Full Text] [Related]  

  • 12. New guidelines for the management of adult community-acquired pneumonia.
    Armitage K; Woodhead M
    Curr Opin Infect Dis; 2007 Apr; 20(2):170-6. PubMed ID: 17496576
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Improving outcomes in elderly patients with community-acquired pneumonia by adhering to national guidelines: Community-Acquired Pneumonia Organization International cohort study results.
    Arnold FW; LaJoie AS; Brock GN; Peyrani P; Rello J; Menéndez R; Lopardo G; Torres A; Rossi P; Ramirez JA;
    Arch Intern Med; 2009 Sep; 169(16):1515-24. PubMed ID: 19752410
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Optimizing the antibiotics policy in The Netherlands. VIII. Revised SWAB guidelines for antimicrobial therapy in adults with community-acquired pneumonia].
    Schouten JA; Prins JM; Bonten M; Degener JE; Janknegt R; Hollander JM; Jonkers R; Wijnands W; Verheij T; Sachs A; Kullberg BJ
    Ned Tijdschr Geneeskd; 2005 Nov; 149(45):2495-500. PubMed ID: 16304886
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Management of community-acquired pneumonia by trained family general practitioners.
    Potena A; Simoni M; Cellini M; Cartabellotta A; Ballerin L; Piattella M; Putinati S
    Int J Tuberc Lung Dis; 2008 Jan; 12(1):19-25. PubMed ID: 18173872
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Evidence for moxifloxacin in community-acquired pneumonia: the impact of pharmaco-economic considerations on guidelines.
    Simoens S
    Curr Med Res Opin; 2009 Oct; 25(10):2447-57. PubMed ID: 19678752
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effectiveness of antimicrobial guidelines for community-acquired pneumonia in children.
    Smith MJ; Kong M; Cambon A; Woods CR
    Pediatrics; 2012 May; 129(5):e1326-33. PubMed ID: 22492769
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Outpatient Antimicrobial Stewardship: Targets for Community-acquired Pneumonia.
    Wattengel BA; Sellick JA; Skelly MK; Napierala R; Schroeck J; Mergenhagen KA
    Clin Ther; 2019 Mar; 41(3):466-476. PubMed ID: 30739721
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Community-acquired pneumonia.
    Irfan M; Farooqi J; Hasan R
    Curr Opin Pulm Med; 2013 May; 19(3):198-208. PubMed ID: 23422417
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Limitations of diagnostic testing in the initial management of patients with community-acquired pneumonia.
    San Pedro GS; Campbell GD
    Semin Respir Infect; 1997 Dec; 12(4):300-7. PubMed ID: 9436957
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.